|
Volumn 15, Issue 9, 2014, Pages 906-907
|
Leukaemia and lymphoma: Why has survival improved?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IMATINIB;
RITUXIMAB;
AGE DISTRIBUTION;
CANCER CLASSIFICATION;
CANCER INCIDENCE;
CANCER MORTALITY;
CANCER SURVIVAL;
CHRONIC MYELOID LEUKEMIA;
DRUG INDUSTRY;
HODGKIN DISEASE;
HUMAN;
LEUKEMIA;
LYMPHOMA;
NONHODGKIN LYMPHOMA;
NOTE;
PRIORITY JOURNAL;
SURVIVAL RATE;
CAUSE OF DEATH;
FEMALE;
HEMATOLOGIC NEOPLASMS;
MALE;
MORTALITY;
CAUSE OF DEATH;
FEMALE;
HEMATOLOGIC NEOPLASMS;
HUMANS;
MALE;
|
EID: 84905055125
PISSN: 14702045
EISSN: 14745488
Source Type: Journal
DOI: 10.1016/S1470-2045(14)70312-2 Document Type: Note |
Times cited : (4)
|
References (6)
|